医学
放射治疗
肿瘤科
化疗
阶段(地层学)
肺癌
内科学
一线治疗
肺
放射科
古生物学
生物
作者
Dawei Chen,Bing Zou,Butuo Li,Aiqin Gao,Wei Huang,Qian Shao,Xiangjiao Meng,Pinliang Zhang,Xiaoxue Li,Xudong Hu,Qian Zhang,Jun Guo,Changhong Zhao,Jiajia Yuan,Q Li,Changbin Zhu,Jinming Yu,Linlin Wang
标识
DOI:10.1016/j.eclinm.2024.102795
摘要
This phase II prospective trial aimed to investigate the efficacy and safety of adebrelimab (PD-L1 antibody) plus first-line chemotherapy followed by sequential thoracic radiotherapy (TRT) combined with adebrelimab in extensive-stage small-cell lung cancer (ES-SCLC). Biomarkers associated with potential therapeutic effects were also explored.
科研通智能强力驱动
Strongly Powered by AbleSci AI